RISK OF INFECTIONS BETWEEN JAK INHIBITORS AND TNF INHIBITORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Choi, S. R. [1 ]
Shin, A. [1 ]
Ha, Y. J. [1 ]
Lee, Y. J. [1 ]
Lee, E. B. [2 ]
Kang, E. H. [1 ]
机构：
[1] Seoul Natl Univ, Div Rheumatol, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[2] Seoul Natl Univ Hosp, Div Rheumatol, Dept Internal Med, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Safety; Rheumatoid arthritis; Disease-modifying drugs (DMARDs);
D O I：
10.1136/annrheumdis-2023-eular.5291
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0836
引用
收藏
页码：716 / 716
页数：1
相关论文
共 50 条
  • [31] Distinct Effects of JAK Inhibitor and TNF Inhibitors on Circulating B Cell Phenotypes in Rheumatoid Arthritis Patients
    Elahee, Mehreen
    Marks, Kathryne
    Adejoorin, Ifeoluwakiisi
    Chen, Lin
    Todd, Derrick
    Coblyn, Jonathan
    Massarotti, Elena
    Ritter, Susan
    Solomon, Daniel
    Weinblatt, Michael
    Rao, Deepak
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1246 - 1248
  • [32] EFFICACY OF JAK INHIBITORS IN REFRACTORY RHEUMATOID ARTHRITIS
    Kamiya, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1468 - 1468
  • [33] Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism with JAK Inhibitors versus TNF Inhibitors in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis
    Partalidou, Styliani
    Patoulias, Dimitrios
    Deuteraiou, Kleopatra
    Avgerou, Paraskevi
    Kitas, George
    Tzitiridou-Chatzopoulo, Maria
    Dimitroulas, Theodoros
    MEDITERRANEAN JOURNAL OF RHEUMATOLOGY, 2024, 35 (01):
  • [34] JAK INHIBITORS: A BROADENING APPROACH IN RHEUMATOID ARTHRITIS
    Lam, S.
    DRUGS OF TODAY, 2016, 52 (08) : 467 - 469
  • [35] THE COMPARISON OF MALIGNANCY RISK BETWEEN JAK INHIBITORS AND TNF INHIBITORS IN MULTICENTER COHORT STUDY
    Uchida, T.
    Iwamoto, N.
    Fukui, S.
    Morimoto, S.
    Aramaki, T.
    Shomura, F.
    Aratake, K.
    Eguchi, K.
    Ueki, Y.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 717 - 718
  • [36] JAK inhibitors: fate in doubt for rheumatoid arthritis?
    不详
    LANCET RHEUMATOLOGY, 2021, 3 (03): : E161 - E161
  • [37] Selective JAK inhibitors in development for rheumatoid arthritis
    Norman, Peter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (08) : 1067 - 1077
  • [38] Chemical JAK inhibitors for the treatment of rheumatoid arthritis
    Nakayamada, Shingo
    Kubo, Satoshi
    Iwata, Shigeru
    Tanaka, Yoshiya
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (16) : 2215 - 2225
  • [39] Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (04) : 306 - 312
  • [40] Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry
    Miyazaki, Yusuke
    Nakayamada, Shingo
    Tanaka, Hiroaki
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Kubo, Satoshi
    Yamaguchi, Ayako
    Miyagawa, Ippei
    Satoh-Kanda, Yurie
    Todoroki, Yasuyuki
    Inoue, Yoshino
    Ueno, Masanobu
    Tanaka, Yoshiya
    RMD OPEN, 2025, 11 (01):
12345